Dave Ricks

UK Chancellor of the Exchequer Rachel Reeves sits down with David Rubenstein for a wide-ranging conversation on the UK's economic outlook, including her efforts to repair public finances. She makes the case for Britain as a global hub for business and talent, highlighting plans t ...  Show more

Jeremy Allaire, Co-Founder, CEO and Chairman of Circle which operates the world’s largest regulated stablecoin network, sits down with David Rubenstein to discuss the company’s IPO last year, his long-term vision for Circle, and the role of artificial intelligence in the labor ma ...  Show more

Benjamin Y. Fong is author of the new book Quick Fixes: Drugs in America from Prohibition to the 21st Century Binge, which was just released in July, 2023 by Verso Books. Ben is an honors faculty fellow and associate director of the Center for Work & Democracy at Arizona State Un ...  Show more

Carl Quintanilla and Jim Cramer led off the show by delving into the broadening market rally, as the S&P 500 and Nasdaq aim for a ninth consecutive day of gains. David Faber called into the show with reporting on Edgar Bronfman's bid to acquire Paramount Global. Eli Lilly CEO ...

Karen Andersen, biotechnology strategist for Morningstar Research Services, discusses what GLP-1 drugs’ demand means for the biopharma industry’s five-year outlook. And whether the weight-loss drugs pose a threat to snack food stocks.

Why GLP-1 Drugs Are in Demand 

We've curated a special 10-minute version of the podcast for those in a hurry.   Here you can listen to the full episode:  https://podcasts.apple.com/no/podcast/eli-lilly-ceo-the-weight-loss-drug-revolution-ai-in/id1614211565?i=1000693848152&l=nb Nicolai Tangen meets with David Ri ...  Show more